Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Also, the geriatric population is more susceptible to incurring brain damage, sensory damage, and suffer from neurological diseases. The increasing geriatric population in the country is expected to drive market growth in the future five years.
The United States brain implants market is segmented by product type, application, end-user, competitional landscape, and regional distribution. Based on product type, the market is further divided into deep brain stimulators, spinal cord stimulators, and vagus nerve stimulators. Deep brain stimulators are medical devices that are electively selected for the procedure of deep brain stimulation as a treatment regime for neurological issues like obsessive-compulsive disorder, Parkinson’s disease, dystonia, essential tremor, epilepsy, and Alzheimer’s disease. In this surgical procedure electrodes (brain implants) are implanted into certain brain areas. These electrodes generate electrical signals that can control abnormal brain functions. The advantages of the surgical process over multiple neurological disorders that have affected the mass population of the country are the key factor driving the growth of the United States brain implants market in the upcoming five years. Moreover, Vagus nerve stimulators are expected to register the fastest CAGR growth in the upcoming five years. These medical devices are used to stimulate the vagus nerve with electrical impulses which aid in the treatment of epilepsy and depression. The rising cases of epilepsy and depression are the major cause of the future growth of the market until 2027.
A partial list of market players in the United States brain implants market includes Medtronic Plc., Boston Scientific Corporation, St. Jude Medical, Inc. (Abbott), Synapse Biomedical Inc, Nevro Corporation, NDI Medical LLC, Terumo Americas Holding, Inc., Edwards Lifesciences Corporation, NeuroPace, Inc., Synchron Inc., among others. These market players hold larger shares of the market than the new market players. With the advancement of technology, it is appropriate to say that the effective research and development of technologically advanced medical devices would support market growth and benefit the market players as well as the consumers. New market players may focus on research and development to provide devices that satisfy consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.
The objective of the Study:
- To analyze the historical growth of the market size of the United States brain implants market from 2017 to 2020.
- To estimate and forecast the market size of the United States brain implants market from 2021 to 2027 and the growth rate until 2027.
- To classify and forecast the United States brain implants market based on product type, application, end-user, competitional landscape, and regional distribution.
- To identify the dominant region or segment in the United States brain implants market.
- To identify drivers and challenges for the United States brain implants market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the United States brain implants market.
- To identify and analyze the profile of leading players operating in the United States brain implants market.
- To identify key sustainable strategies adopted by market players in the United States brain implants market.
The publisher calculated the market size of the United States brain implants market using a bottom-up approach, wherein data for various end-user segments were recorded and forecasted for the future years. The publisher sourced these values from industry experts and company representatives and externally validated them by analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations, and financial reports were also studied.
Key Target Audience:
- Brain implants manufacturers, end users, and other stakeholders
- Distributors and suppliers of the products and other stakeholders
- Organizations, forums, and alliances related to brain implants
- Market research and consulting firms
Report Scope:
In this report, the United States brain implants market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:United States Brain Implants Market, By Product Type:
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagus Nerve Stimulators
United States Brain Implants Market, By Application:
- Chronic Pain
- Epilepsy
- Parkinson’s Disease
- Depression
- Essential Tremor
- Alzheimer’s Disease
United States Brain Implants Market, By End User:
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Others
United States Brain Implants Market, By Region:
- South
- West
- Mid-West
- North East
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the United States brain implants market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs.This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Medtronic Plc.
- Boston Scientific Corporation
- St. Jude Medical, Inc. (Abbott)
- Synapse Biomedical Inc
- Nevro Corporation
- NDI Medical LLC
- Terumo Americas Holding, Inc.
- Edwards Lifesciences Corporation
- NeuroPace, Inc.
- Synchron Inc